OTC · Drug Manufacturers - Specialty & Generic

Bio Essence Corporation (BIOE) Stock

$0.25 +37.44% OTC: BIOE Healthcare

Bio Essence Corporation is a global enterprise specializing in herbal health, dietary, and nutritional solutions. It supplies healthcare professionals with a diverse range of herbal remedies, offered in various forms such as granules, capsules, pills, and tablets.

Valuation

MetricValue
Price$0.25
Market Cap$9.90M
P/E Ratio7.44
P/B Ratio-7.87
P/S Ratio4.17
EPS (TTM)$0.03
52-Week High$0.52
52-Week Low$0.05
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-53.81%
ROA165.69%
ROCE-96.29%
Gross Margin72.70%
Operating Margin55.60%
Net Margin55.02%
Debt/Equity-1.10
Current Ratio0.37

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$1.0M$1.0M$0$2.0M
Operating Profit$-1.0M$-1.0M$-1.0M$0$1.0M
Net Profit$-1.0M$-1.0M$-1.0M$-1.0M$1.0M
EPS$-0.02$-0.02$-0.02$-0.03$0.02
Op Margin-96.6%-82.2%-143.1%-141.8%47.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.0M$2.0M$3.0M$0$0
Total Liabilities$4.0M$5.0M$4.0M$3.0M$2.0M
Cash$0$0$0$0$0
Borrowings$4.0M$5.0M$3.0M$3.0M$2.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-1.0M$-1.0M$1.0M$2.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$1.0M$1.0M$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$-1.0M$-1.0M$-1.0M$1.0M$2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA8.65
FCF Yield11.96%
Quick Ratio0.37
Interest Coverage604.53
Return 1Y121.24%
Return 3Y
Return 5Y

Ownership

Insiders Held73.48%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CRYMCryomass Technologies Inc. $0.00 0.00 $47432 0.00%
LMLLFPharmadrug Inc. $0.01 +17.46% -2.33 $993184 0.00%
LVVVLiveWire Ergogenics, Inc. $0.00 0.44 $761592 0.00%
NRPRResilient Healthcare Corp $0.02 +0.00% $2.11M 0.00%
RAFARafarma Pharmaceuticals, Inc. $0.02 +0.00% 10.43 $2.11M 0.00%

About Bio Essence Corporation

Bio Essence Corporation is a global enterprise specializing in herbal health, dietary, and nutritional solutions. It supplies healthcare professionals with a diverse range of herbal remedies, offered in various forms such as granules, capsules, pills, and tablets. Furthermore, the company extends custom formulation and original equipment manufacturing (OEM) services to these practitioners and manufactures and distributes its own line of health supplements. Founded in 2000, Bio Essence Corporation maintains its corporate headquarters in Irvine, California.

Bio Essence Corporation is headquartered in US.

Bio Essence Corporation (BIOE) stock trades at $0.25 with a market capitalization of $9.90M. The stock is valued at a price-to-earnings (P/E) ratio of 7.44, price-to-book of -7.87, price-to-sales of 4.17. Over the past 52 weeks the stock has ranged between $0.05 and $0.52, and currently trades 51.9% below its 52-week high.

On profitability, Bio Essence Corporation generates a return on equity (ROE) of -53.81%, return on capital employed of -96.29%, an operating margin of 55.60%, a net profit margin of 55.02%.

Official website: www.bioessencecorp.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides